Spinal Muscular Atrophy Trial, Recruiting NCT05726591 Sponsor: National Institutes of Health Clinical Center (CC) Condition: Spinal Muscular Atrophy
Back to Spinal Muscular Atrophy

Spinal Muscular Atrophy Trial, Recruiting

NCT05726591
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to sign a consent form and agree to follow all study procedures for the full duration of the trial.
  • You are between 3 and 17 years old.
  • You have a walking difficulty related to the knee joint, caused by cerebral palsy, muscular dystrophy, spina bifida, or an incomplete spinal cord injury.
  • Your knee can bend and straighten by at least 25 degrees when lying on your back with your hip flat (confirm with trial site).
  • Your ankle can move up and down by at least 15 degrees when the foot is in a neutral position (confirm with trial site).
  • The angle of your foot relative to your thigh, when lying face down, falls within a specific range (confirm with trial site).
  • You are able to walk at least 10 feet without stopping, with or without a walking aid.

Who may not be able to join:

  • You have any other nerve, muscle, bone, heart, or breathing condition — beyond the four listed diagnoses — that would affect your ability to walk while wearing a robotic leg brace.
  • You have had uncontrolled seizures at any point in the past year.
  • You are pregnant (a urine test will be done at the first visit for anyone who could become pregnant, and self-reporting will be used throughout the study).
  • You have a heart or lung condition that means you cannot exercise for at least 60 minutes per session or at least 5 days per week.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Thomas C Bulea, Ph.D., National Institutes of Health Clinical Center (CC)

Phone: (301) 451-7533

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Institutes of Health Clinical Center (CC)
Registry
ClinicalTrials.gov
Start date
2 May 2023
Est. completion
31 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

To evaluate the effectiveness of a longitudinal exoskeleton training program in the community, as opposed to a standard regimen of therapy of the same magnitude, at improving knee extension deficiency in children with CP, SB, iSCI or MD.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov